Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent

Isoliquiritigenin (ISL), a natural product isolated from licorice root, exhibits anti-gastric cancer effects. However, applications of ISL are still limited in clinical practice due to its poor bioavailability. To discovery of more effective anti-gastric cancer agents based on ISL, aldol condensatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fengchang, Wang, Jin, Xu, Yi, Zhang, Yunfei, Xu, Ning, Yin, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Therapeutics & Molecular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306486/
https://www.ncbi.nlm.nih.gov/pubmed/32515470
http://dx.doi.org/10.1042/BSR20201199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306486/
https://www.ncbi.nlm.nih.gov/pubmed/32515470
http://dx.doi.org/10.1042/BSR20201199

Ejemplares similares